Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE2
Sponsor: Georgetown University
Condition: Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT07645326
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: complex_intervention_signal
Stopped reason
Context when available
No stop reason available in the current public record.